Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.7K Buy
1,469
+416
+40% +$18.6K 0.02% 206
2026
Q1
$50.7K Sell
1,053
-274
-21% -$12.8K 0.02% 207
2025
Q4
$64.3K Sell
1,327
-211
-14% -$10.5K 0.03% 193
2025
Q3
$72.6K Buy
1,538
+273
+22% +$13.2K 0.03% 152
2025
Q2
$61.1K Sell
1,265
-123
-9% -$6.29K 0.03% 160
2025
Q1
$77K Buy
1,388
+108
+8% +$5.85K 0.05% 119
2024
Q4
$61.7K Buy
1,280
+173
+16% +$8.8K 0.04% 141
2024
Q3
$63.8K Hold
1,107
0.04% 141
2024
Q2
$53.7K Sell
1,107
-191
-15% -$9.21K 0.04% 145
2024
Q1
$63.1K Buy
1,298
+604
+87% +$29.5K 0.05% 133
2023
Q4
$34.5K Buy
+694
New +$33.9K 0.03% 174

Other funds holding SNY

WealthCollab's SNY Position: Q2 2026 in Review

WealthCollab increased its Sanofi (SNY) stake by 40% in Q2 2026, buying an estimated $18.6K and bringing the position to 1,469 shares worth $62.7K. The position accounts for 0.02% of the portfolio, ranked #206.

WealthCollab first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $77K in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • WealthCollab held 1,469 shares of Sanofi worth $62.7K as of Q2 2026.
  • WealthCollab bought 416 Sanofi shares in Q2 2026, an estimated $18.6K.
  • Sanofi made up 0.02% of WealthCollab's portfolio in Q2 2026, its #206 holding.
  • WealthCollab first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Sanofi position peaked at $77K in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.